Haemophilia and thrombosis research
Oxford Haemophilia and Thrombosis Centre is very active in clinical research, participating in many national and international studies.
If you have haemophilia, or other rare conditions, you are very likely to be asked to consider taking part in a study to help improve future treatment. This could range from answering a few questions and/or a single blood test, through to trialling a new treatment over a number of years.
The choice to take part in research is entirely yours. If you prefer not to take part, your decision will be respected by your team and it will not affect the care you receive.
Research areas include:
- novel non-factor haemophilia treatment
- selection of viruses for gene therapy in haemophilia
- long-acting factor treatments
- joint disease in haemophilia
- genetics of rare bleeding conditions
- use of novel oral anticoagulants in cancer patients
- long-term treatment outcomes of patients with DVT and/or PE.
If you are interested in taking part or being involved in any research studies taking place at the Centre, contact Haemophilia Reception and ask to speak to the Research Specialist Nurse.
Tel: 01865 225316
For a list of current and recent studies within the Oxford Haemophilia and Thrombosis Centre, please see the table at the link below:
Research studies September 2020 (pdf, 372 KB)
Oxford Blood Group
Oxford Blood Group encourages patients and members of the public to be involved with Haematology Research at the Oxford Biomedical Research Centre.
For further information please email: oxfordbloodgroup@ouh.nhs.uk
or visit the following websites:
Oxford Blood Group - oxfordbrc.nihr.ac.uk
Our Work with Patients and the Public - oxfordbrc.nihr.ac.uk